NCT03726827View on ClinicalTrials.gov

A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations

CompletedOBSERVATIONAL
Enrollment

1,006

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

August 30, 2019

Study Completion Date

August 31, 2019

Conditions
NAFLDNASH - Nonalcoholic SteatohepatitisCirrhosis, LiverFatty Liver
Interventions
OTHER

Fibroscan screening

A single Fibroscan screening for fat content and liver stiffness

Trial Locations (1)

77590

Fatty Liver Foundation, Texas City

All Listed Sponsors
lead

Fatty liver Foundation

OTHER

NCT03726827 - A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations | Biotech Hunter | Biotech Hunter